Prevention of hemolysis

Details Prevention of hemolysis Prevention of hemolysis

1991-09-19

1995-08-29

Griffin, Ronald W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

536103, 514832, 514833, A61K 3156, A61K 31715, C07H 100, C08B 3716

Patent

active

054460301

ABSTRACT:
Disclosed are compositions and methods for prevented or substantially inhibiting the hemolytic activity of hemolysis inducing agents. The methods and compositions are based on the use an anionic oligosaccharide, such as polysulfated cyclodextrin, to achieve the desired reduction in hemolytic active inducing agents.

REFERENCES:
patent: 3420788 (1969-01-01), Solms
patent: 4020160 (1977-04-01), Bernstein et al.
patent: 4066829 (1978-01-01), Nair et al.
patent: 4247535 (1981-01-01), Lewis et al.
patent: 4258180 (1981-03-01), Lewis et al.
patent: 4352794 (1982-10-01), Koch
patent: 4383992 (1983-05-01), Lipari
patent: 4582900 (1986-04-01), Brandt et al.
patent: 4596795 (1986-06-01), Pitha
patent: 4703042 (1987-10-01), Bodor
patent: 4727064 (1988-02-01), Pitha
patent: 4764604 (1988-08-01), Muller
patent: 4834985 (1989-05-01), Elger et al.
patent: 4840941 (1989-06-01), Ueno et al.
patent: 4877774 (1989-10-01), Pitha et al.
patent: 4877778 (1989-10-01), Carpenter et al.
patent: 4902788 (1990-02-01), Zemel et al.
patent: 4983586 (1991-01-01), Bodor
patent: 5002935 (1991-03-01), Bodor
patent: 5017566 (1991-05-01), Bodor
patent: 5019562 (1991-05-01), Folkman et al.
patent: 5024998 (1991-06-01), Bodor
patent: 5068226 (1991-11-01), Weinshenker et al.
patent: 5100878 (1992-03-01), Geber
patent: 5183809 (1993-02-01), Weisz et al.
Alberts et al., "Molecular Biology of the Cell", Garland Publishing, Inc., New York, N.Y., 1983, pp. 702-709.
The Merck Index, Eleventh Edition, Susan Budavari et al. editor, Published by Merck & Co., Inc. Rahway, N.J., U.S.A., 1989, p. 256.
K. Uekama et al., J. Pharm. Pharmacol., vol. 33, pp. 707-710 (1981).
W. Saenger, Angew. Chem. Int. Ed. Engl., vol. 19, pp. 344-362 (1980).
K. Uekama et al., Chem. Pharm. Bull., vol. 37, pp. 76-80 (1979).
Y. Sato et al., Yakugazu Zasshi, vol. 102 (1982) pp. 874-880.
T. Irie et al., J. Pharm. Dyn., vol. 6, pp. 408-414 (1983).
K. Masuda et al., Yakugazu Zasshi, vol. 104, pp. 1075-1082 (1982).
T. Irie et al., J. Pharm. Dyn., vol. 5, pp. 741-744 (1982).
J. Follezoa et al., J. Biomed. Pharmacother. vol. 36, pp. 326-328 (1982).
I. Jodal et al., Proceedings of the Fourth International Symposium on Cyclodextrins, O. Huber and J. Szejtli, Eds., 421-425, Kluwer Academic Publishers, Boston (1988).
Clay and Clay Minerals, vol. 34, pp. 74-80 (1986).
Nakashima et al., Antimicrobial Agents and Chemotherapy, pp. 1524-1528 (1987).
Uekama et al., International Journal of Pharmaceutics, vol. 10, pp. 1-15 (1982).
J. Pitha et al., Journal of Pharmaceutical Sciences, vol. 75(2), pp. 165-167 (1986).
Yamamoto et al., International Journal of Pharmaceutics, vol. 49, pp. 163-171 (1989).
Chemical Abstracts, 96:218351u (1982).
Croft et al., Tetrahedron, vol. 39, pp. 1417-1474 (1983).
Fenyvesi et al., Chem. Pharm. Bull., vol. 32(2), pp. 665-669 (1984).
Fenyvesi et al., Chem. Pharm. Bull., vol. 32(2), pp. 670-677 (1984).
Komiyama et al., Polymer Journal, vol. 18(4), pp. 375-377 (1986).
Herrmann, H. C., Abstracts of Papers, National Meeting of the American Heart Association, Anaheim, Calif.; Nov. 11-14, 1991.
Chemical Abstracts 83:79544a (1975).

Affiliated with

Also associated with

Rating

Prevention of hemolysis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prevention of hemolysis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention of hemolysis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1819520